CBIO Financial Model
Quarterly and annual income statement, cash flow and balance sheet line items for Crescent Biopharma, Inc.: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding. Latest statement: Jun 30, 2026.